Which hedge funds own CVS? CVS HEALTH CORP, Q2 2026 13F holders
Healthcare · Open on the interactive board
17 of the hedge funds tracked by WhaleCreep disclosed a position in CVS (CVS HEALTH CORP) in their Q2 2026 13F filings, worth $2.6bn in total. The largest holder by portfolio weight is Glenview Capital Management at 10.0% of its book. 3 managers opened a new position this quarter: Viking Global Investors, Point72 Asset Management LP, Suvretta Capital Management. 3 exited: Maverick Capital, Senator Investment Group, Tweedy Browne.
17tracked managers holding
3opened this quarter
3exited this quarter
Which hedge funds hold CVS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Glenview Capital Management | Q2 2026 | 10.0% | $499.1m | 4,824,799 | -41% | reduced |
| Viking Global Investors | Q2 2026 | 1.1% | $379.0m | 3,663,361 | – | new |
| Holocene Advisors | Q2 2026 | 0.7% | $310.5m | 3,001,684 | -33% | reduced |
| Davidson Kempner Capital Management | Q2 2026 | 0.4% | $23.4m | 226,036 | 182% | added |
| Woodline Partners | Q2 2026 | 0.3% | $112.1m | 1,083,859 | 459% | added |
| Point72 Asset Management LP | Q2 2026 | 0.3% | $202.9m | 1,961,032 | – | new |
| Citadel Advisors | Q2 2026 | 0.3% | $497.9m | 4,812,530 | -11% | reduced |
| Bridgewater Associates | Q2 2026 | 0.2% | $45.6m | 440,972 | -29% | reduced |
| Suvretta Capital Management | Q2 2026 | 0.2% | $8.7m | 84,500 | – | new |
| Tudor Investment | Q2 2026 | 0.2% | $38.3m | 370,000 | -46% | reduced |
| Millennium Management | Q2 2026 | 0.2% | $224.0m | 2,164,833 | 1014% | added |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $143.0m | 1,382,037 | -15% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.1% | $5.3m | 51,694 | -31% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $45.6m | 441,016 | 68% | added |
| Marshall Wace | Q2 2026 | 0.0% | $33.6m | 325,000 | -60% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $3.7m | 36,168 | -1% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $395.7k | 3,825 | -33% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Maverick Capital | 0.0% | $680.3k |
| Senator Investment Group | 2.5% | $12.6m |
| Tweedy Browne | 3.0% | $1.4m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.0% |
How has hedge fund ownership of CVS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 17 | $2.6bn |
| Q1 2026 | 17 | $1.6bn |
| Q4 2025 | 13 | $1.6bn |
| Q3 2025 | 13 | $1.3bn |
| Q2 2025 | 11 | $1.2bn |
| Q1 2025 | 12 | $1.6bn |
| Q4 2024 | 11 | $780.5m |
| Q3 2024 | 13 | $1.2bn |
| Q2 2024 | 11 | $936.1m |
| Q1 2024 | 9 | $413.4m |
| Q4 2023 | 14 | $608.0m |
| Q3 2023 | 11 | $344.7m |
| Q2 2023 | 12 | $358.2m |
| Q1 2023 | 13 | $648.1m |
| Q4 2022 | 13 | $637.8m |
| Q3 2022 | 10 | $672.7m |
Counts every tracked manager that disclosed CVS in that quarter's filing, including managers that have since stopped filing.